Novo Nordisk A/S’s blockbuster diabetes drug Ozempic cut patients’ risk of dying in a kidney-disease study, the latest research pointing to the medicine’s usefulness in a constellation of disorders.
Source link
Novo’s Ozempic Slashes Risk of Death in Kidney Disease Study
Ernold Media
Cyber Security - May 24, 2024
- 0 Comments
Related Posts
- August 7, 2024
- 0 Comments
Vista Winds Down Hedge Fund, Citing Dominance of Private Markets
Vista Equity Partners has told investors it’s winding down its hedge fund amid a “structural shift” in markets toward private assets. Source link
- August 7, 2024
- 0 Comments
T-Mobile Postpones $561 Million Wireless Equipment ABS Offering
T-Mobile US Inc. is postponing its sale of more than $500 million in asset backed securities supported by wireless equipment plans, according to people familiar with the matter. Source link
